SUBSCRIBE
SUBSCRIBE
Gail Dutton

Gail Dutton

Freelance writer

Gail Dutton is a veteran biopharmaceutical reporter, covering the industry from Washington state. You can contact her at gaildutton@gmail.com and see more of her work on Muckrack.

Omid Veiseh, Ph.D._Avenge Bio
Drug Development
Cytokine Factory Destroys 100% of Intraperitoneal Tumors in Early Studies
The platform, called LOCOcyte™, is a cytokine delivery platform that is made of polymer-encapsulated human ARPE-19 cells that produce natural cytokines.
March 21, 2022
 · 
4 min read
 · 
Gail Dutton
Operation Warp Speed_ Bill Oxford/Getty Images
Business
Book Review: Warp Speed – One of the Most Successful Private-Public Partnerships
In his new book, Warp Speed, Paul Mango said the realization that many healthcare workers didn’t want the vaccine, for instance, was shocking.
March 16, 2022
 · 
5 min read
 · 
Gail Dutton
Drug Development
Digital Twin Studies: the Next Inflection in Equal, Equitable, Healthcare
The Media and Innovation Lab at the University of Miami is developing digital twins of patients in an effort to bring robust healthcare to underserved communities.
March 16, 2022
 · 
4 min read
 · 
Gail Dutton
Photos courtesy of LinkedIn, Paul Mango
Business
Behind the Scenes at Operation Warp Speed with Paul Mango
BioSpace talked with Paul Mango, one of the key leaders of Operation Warp Speed, about the experience.
March 14, 2022
 · 
6 min read
 · 
Gail Dutton
NRX-101
Drug Development
HMNC Pioneers Precision Medicine for Psychiatry with Companion Diagnostics
The identification of multiple genomic markers that are linked to specific mental health diseases is beginning to improve treatments and enable precision psychiatry.
March 10, 2022
 · 
4 min read
 · 
Gail Dutton
Example of False Add_Pharmaceutical Security Insti
Cybercrime Explodes as Pharma Financial Fraud Challenges Counterfeiting
Financial fraud committed by supposed online pharmacies may be as big a threat to society as counterfeit medicines.
March 10, 2022
 · 
4 min read
 · 
Gail Dutton
Business
Genomics is Only the First Step in Developing Effective Cancer Treatments
Before next-generation metabolomics becomes mainstream, the medical establishment needs to expand its mindset around cancer and translate this understanding into the clinic.
March 9, 2022
 · 
5 min read
 · 
Gail Dutton
Using real-world evidence devices can help evaluat
Business
FDA Commissioner Califf and the Potential of Real-World Evidence in Clinical Trials
Robert Califf became the new commissioner of the U.S. Food & Drug Administration and emphasized the use of real-world evidence (RWE) in Agency decisions.
March 5, 2022
 · 
5 min read
 · 
Gail Dutton
Drug Development
ABVC Biopharma Rallies Active Herbal Ingredients Against Cancer, MDD & ADHD
ABVC Biopharma, based in California, has programs in Phase II trials to treat major depressive disorder, adult attention deficit hyperactivity disorder and myelodysplastic syndrome.
March 3, 2022
 · 
5 min read
 · 
Gail Dutton
Drug Development
Gene Therapy Trials for Sickle Cell Disease Hold Hope for Durable Effects
Recent gene therapy research has created a durable response in terms of producing normally-shaped red blood cells and reducing the pain of sickle cell disease.
March 2, 2022
 · 
4 min read
 · 
Gail Dutton
Nick Otto For The Washington Post via GI
Business
IGI Launches “Women in Enterprising Science Program” to Foster Genomic Entrepreneurs
WIES fellows will have access to successful female entrepreneurs, including CRISPR pioneer and Nobel laureate Jennifer Doudna, who founded the IGI.
March 1, 2022
 · 
4 min read
 · 
Gail Dutton
Deals
Prioritize Programs and Preserve Resources to Weather 2022 Market Volatility
That’s the advice for emerging growth life sciences companies in 2022, according to attorney Frank Rahmani, partner in the global life science and capital markets practice group at Sidley Austin LLP.
February 28, 2022
 · 
5 min read
 · 
Gail Dutton
Courtesy of Getty Images
Business
Veru/Lilly Aim to Fill Gap in Second-Line Metastatic Breast Cancer Therapy
Veru’s enobosarm shows good proof of concept data even when 90% of patients have failed first-line therapies.
February 23, 2022
 · 
4 min read
 · 
Gail Dutton
Feline DNA Kit_courtesy Basepaws
Biotech Beach
Basepaws’ Cat DNA Kit Warns of Pending Diseases and Defines Breed
“We were founded on the premise of felines first, and have been called ‘23andMeow,’ Anna Skaya, founder and CEO, told BioSpace.
February 21, 2022
 · 
5 min read
 · 
Gail Dutton
Business
The Debate: Should Gene Editing Be Used to Make Better Babies?
BioSpace covers the Intelligence Squared U.S. debate: Will gene editing enable a healthier, more diverse, more equitable population, or will it create market-born eugenics and a dystopian society?
February 21, 2022
 · 
5 min read
 · 
Gail Dutton
Load More